Assessing the Efficacy and Safety of DEXTENZA in Pseudo Phakic Patients Undergoing Gas Bubble Repair and Laser Following Retinal Detachment

Summary

This prospective, open-label, single-center, randomized, investigator-sponsored clinical study seeks to investigate: how will pseudophakic patients respond in terms of objective and subjective outcomes, when treated with Dextenza compared to topical prednisolone acetate following gas bubble repair and laser for RD.

Timeline

Start

2020-07-14

Primary completion

2023-01-25

Completion

2023-01-25

Outcome

Outcome not reported

Stopped (Enrollment): “Poor enrollment”

Drugs

Indications